Works matching IS 10781552 AND DT 2024 AND VI 30 AND IP 7
Results: 22
A systematic approach to the management of menses prophylaxis and suppression in pre-menopausal hematologic cancer patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1259, doi. 10.1177/10781552241266587
- By:
- Publication type:
- Article
Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1255, doi. 10.1177/10781552241265884
- By:
- Publication type:
- Article
Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1268, doi. 10.1177/10781552241264530
- By:
- Publication type:
- Article
Immune checkpoint blockade effect on immunologic and virologic profile of five cancer patients living with human immunodeficiency virus (HIV) infection.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1249, doi. 10.1177/10781552241264258
- By:
- Publication type:
- Article
Enhancing access to expensive oncology medications in Pakistan: The critical role of pharmaceutical patient assistance programs in oncology care.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1287, doi. 10.1177/10781552241280664
- By:
- Publication type:
- Article
Oral lichenoid drug eruption due to osimertinib for lung cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1278, doi. 10.1177/10781552241268693
- By:
- Publication type:
- Article
Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1274, doi. 10.1177/10781552241268468
- By:
- Publication type:
- Article
Medical marijuana in the treatment of cancer-associated symptoms.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1240, doi. 10.1177/10781552241262963
- By:
- Publication type:
- Article
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1214, doi. 10.1177/10781552241260864
- By:
- Publication type:
- Article
Cold-associated laryngopharyngeal dysesthesia syndrome after oxaliplatin treatment.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1245, doi. 10.1177/10781552241255289
- By:
- Publication type:
- Article
Utilization of cefepime therapeutic drug monitoring in febrile neutropenia patients with hematologic malignancies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1207, doi. 10.1177/10781552231213883
- By:
- Publication type:
- Article
Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1200, doi. 10.1177/10781552231207854
- By:
- Publication type:
- Article
Out-of-hours admissions in patients treated with immune checkpoint inhibitors and their primary management with steroids.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1193, doi. 10.1177/10781552231207271
- By:
- Publication type:
- Article
Olanzapine within steroid-sparing antiemetic regimen to prevent chemotherapy-induced nausea and vomiting in patients with acute leukemia receiving multi-day intensive chemotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1186, doi. 10.1177/10781552231205824
- By:
- Publication type:
- Article
Longitudinal evaluation of environmental contamination with hazardous drugs by surface wipe sampling.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1181, doi. 10.1177/10781552231205481
- By:
- Publication type:
- Article
Real world practices of luspatercept at an academic medical center.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1173, doi. 10.1177/10781552231203721
- By:
- Publication type:
- Article
Efficacy and safety of bone management agents administered at 12 weeks vs. 4 weeks in patients with bone metastases: A systematic review.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1160, doi. 10.1177/10781552231203720
- By:
- Publication type:
- Article
Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1152, doi. 10.1177/10781552231203403
- By:
- Publication type:
- Article
Therapeutic adherence and assessment of satisfaction patients with multiple myeloma treated with immunomodulatory drugs in a "real-world" study: Experiences of the Polish Myeloma Group.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1144, doi. 10.1177/10781552231203371
- By:
- Publication type:
- Article
Clinical and economic impact of oncology-trained pharmacist integration in an ambulatory cancer clinic.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1138, doi. 10.1177/10781552231202221
- By:
- Publication type:
- Article
Impact of pegaspargase dose capping on incidence of pegaspargase-related adverse events in adults.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1130, doi. 10.1177/10781552231202217
- By:
- Publication type:
- Article
Leukocytoclastic vasculitis associated with capecitabine.
- Published in:
- Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 7, p. 1282, doi. 10.1177/10781552231167812
- By:
- Publication type:
- Article